Z-1612-2016 Class II Terminated

Recalled by Philips Electronics North America Corporation — Andover, MA

FDA device recall Z-1612-2016 was initiated by Philips Electronics North America Corporation on Apr 14, 2016 and is designated Class II. Reason for recall: MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component. The recall status is terminated (terminated Mar 27, 2019). Affected quantity: 17.

Recall details

Product Type
Devices
Report Date
May 11, 2016
Initiation Date
Apr 14, 2016
Termination Date
Mar 27, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17

Product description

HeartStart MRx Monitor/Defibrillator The HeartStart MRx is for use for the termination of ventricular tachycardia and ventricular fibrillation. The device is for use by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac support, or defibrillation. It must be used by or on the order of a physician.

Reason for recall

MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component.

Distribution pattern

Worldwide Distribution - US including OH, CA, NC and Internationally to China, Iraq, Japan, and Korea.

Code information

US00586611, US00589878, US00594232, US00588464, US00591080, US00594779, US00588657, US00592182, US00594913, US00589391, US00593861, US00595298, US00589472, US00594092, US00595443, US00589851, US00594168

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1612-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1612-2016. Report a data issue: hello@regdatalab.com.